Prediction of intestinal absorption:: comparative assessment of GASTROPLUS ™ and IDEA ™

We have assessed two commercial software tools employing physiologically based models for prediction of intestinal absorption in human. IDEA(TM) 2.0 and GASTROPLUS(TM) 3.1.0 were compared both in their ability to predict fraction absorbed for a set of 28 drugs and in terms of the functionality offered. The emphasis was placed on the practical usefulness to pharmaceutical drug discovery. Predictions were assessed for three levels of input data (i) pure in silico input, (ii) thermodynamic solubility and in silico permeability, (iii) thermodynamic solubility and human colon carcinoma cell line (CACO-2) permeability. We found the pure in silico prediction ability of the tools to be comparable with 70% correct classification rate. With measured input data the IDEA(TM) prediction rate improved to 79% while GASTROPLUS(TM) stayed at 70%. In terms of functionality GASTROPLUS(TM) is a powerful system for the trained user. Open access to model parameters, diagnostic tools and the ability to integrate data make it particularly suitable for the later stages of discovery and development. IDEA(TM) is web based and presents a simple interface suitable for widespread use with minimal training. However the limited functionality and inconvenient handling of multiple compound batches currently restrict the usefulness of version 2.0 for drug discovery. (C) 2002 Elsevier Science B.V. All rights reserved.